Pfizer (PFE) has named Chris Boshoff, who has led the company’s cancer research and marketing for more than a year, as its chief scientific ...

The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...

Drug major Pfizer Inc. (PFE) announced Wednesday the appointment of Chris Boshoff as Chief Scientific Officer and President, Research ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Chinese electric vehicle giant BYD plans to build the fourth phase of its industrial park in southern China's ...

Activist hedge fund manager Jeff Smith outlined his concerns about drugmaker Pfizer on Tuesday but stopped short of offering a solution — saying that's a job for the board of directors.

Pfizer (NYSE: PFE) is scheduled to report its Q3 2024 results on Tuesday, October 29. We expect the company to post revenue of $15.1 billion and earnings of $0.63 on a per share and adjusted basis ...

(Reuters) - Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...

Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high ...

Paxlovid sales surge to $2.7 billion, beating expectations Pfizer raises annual revenue forecast for COVID products to $10.5 billion Pfizer management faces pressure from activist hedge fund ...

The shots are also suggested for certain adults and children who are immunocompromised. A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by ...